Fortress Biotech, Inc.
Fortress Biotech, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2010, the company focuses on developing and commercialising innovative therapies for rare and complex diseases. With a robust portfolio of products, Fortress Biotech stands out for its unique approach to drug development, leveraging its extensive network of subsidiaries and partnerships to enhance its market position. The company operates primarily in the fields of oncology and rare diseases, with a commitment to addressing unmet medical needs. Notable achievements include the successful advancement of several drug candidates through clinical trials, showcasing its dedication to innovation and patient care. Fortress Biotech continues to solidify its reputation as a leader in the biopharmaceutical sector, driven by a mission to improve patient outcomes through cutting-edge therapies.
DitchCarbon Score
How does Fortress Biotech, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fortress Biotech, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fortress Biotech, Inc.'s reported carbon emissions
Fortress Biotech, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Fortress Biotech has not inherited any emissions data from a parent or related organization, nor does it have any commitments to the Science Based Targets initiative (SBTi) or other climate initiatives. This lack of data and commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the biotechnology industry, it is increasingly important for companies to establish clear climate commitments and reduction targets to align with global sustainability goals. Without specific emissions data or reduction initiatives, Fortress Biotech's climate impact remains unclear.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fortress Biotech, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
